Ceribell (CBLL) Cash & Equivalents (2023 - 2026)
Ceribell (CBLL) posted Cash & Equivalents of $45.3 million for Q1 2026, up 11.8% on a QoQ basis from $40.5 million in Q4 2025, and down 70.49% year-over-year from $153.4 million in Q1 2025.
Ceribell (CBLL) Cash & Equivalents (2023 - 2026) Analysis & Trends
Ceribell's Cash & Equivalents history runs 4 years deep, the most recent figure standing at $45.3 million for Q1 2026.
- Quarterly Cash & Equivalents fell 70.49% year-over-year to $45.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.3 million (down 70.49% YoY) and the FY2025 annual result came in at $40.5 million, down 79.18% from the prior year.
- Cash & Equivalents was $45.3 million for Q1 2026 at Ceribell, up from $40.5 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $194.4 million in Q4 2024 and bottomed at $14.1 million in Q3 2024.
- A 4-year average of $68.2 million and a median of $40.3 million in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents soared 463.47% — and 2025, when it tumbled 79.18%.
- Ceribell's Cash & Equivalents stood at $34.5 million in 2023, then surged by 463.47% to $194.4 million in 2024, then tumbled by 79.18% to $40.5 million in 2025, then increased by 11.8% to $45.3 million in 2026.
- Business Quant data shows CBLL's Cash & Equivalents at $45.3 million in Q1 2026, $40.5 million in Q4 2025, and $23.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 45.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.25 Mn |
| Dec 31, 2025 | 40.48 Mn |
| Sep 30, 2025 | 23.74 Mn |
| Jun 30, 2025 | 40.14 Mn |
| Mar 31, 2025 | 153.36 Mn |
| Dec 31, 2024 | 194.37 Mn |
| Sep 30, 2024 | 14.10 Mn |
| Dec 31, 2023 | 34.50 Mn |